Jazz Pharmaceuticals (JAZZ) FCF Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Jazz Pharmaceuticals | 14.64 Bn | 12.79 Bn | 934.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,558.00 |
| Dec 31, 2025 | 150.00 |
| Sep 30, 2025 | 7,225.00 |
| Jun 30, 2025 | -10,420.00 |
| Mar 31, 2025 | -382.00 |
| Dec 31, 2024 | 2,276.00 |
| Sep 30, 2024 | -2,158.00 |
| Jun 30, 2024 | 642.00 |
| Mar 31, 2024 | -937.00 |
| Dec 31, 2023 | -2,916.00 |
| Sep 30, 2023 | -1,519.00 |
| Jun 30, 2023 | -713.00 |
| Mar 31, 2023 | -54.00 |
| Dec 31, 2022 | -1,063.00 |
| Sep 30, 2022 | 112.00 |
| Jun 30, 2022 | -102.00 |
| Mar 31, 2022 | -1,863.00 |
| Dec 31, 2021 | -2,653.00 |
| Sep 30, 2021 | -321.00 |
| Jun 30, 2021 | -2,780.00 |
| Mar 31, 2021 | 215.00 |
| Dec 31, 2020 | -677.00 |
| Sep 30, 2020 | -749.00 |
| Jun 30, 2020 | -624.00 |
| Mar 31, 2020 | 2,359.00 |
| Dec 31, 2019 | -2,292.00 |
| Sep 30, 2019 | 2,106.00 |
| Jun 30, 2019 | 335.00 |
| Mar 31, 2019 | 1,183.00 |
| Sep 30, 2018 | -4,089.00 |
| Jun 30, 2018 | 205.00 |
| Mar 31, 2018 | 100.00 |
| Dec 31, 2017 | -1,143.00 |
| Sep 30, 2017 | 2,011.00 |
| Jun 30, 2017 | -2,799.00 |
| Mar 31, 2017 | 1,939.00 |
| Dec 31, 2016 | -612.00 |
| Sep 30, 2016 | -2,835.00 |
| Jun 30, 2016 | -2,645.00 |
| Mar 31, 2016 | -352.00 |
| Dec 31, 2015 | 699.00 |
| Sep 30, 2015 | 2,506.00 |